These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10795154)

  • 1. [A new procedure improves microcirculation. Controlled fibrinogen depletion should save diabetic feet].
    Einecke U
    MMW Fortschr Med; 1999 Nov; 141(46):62-3. PubMed ID: 10795154
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the microcirculation in diabetic foot ulceration.
    Korzon-Burakowska A; Edmonds M
    Int J Low Extrem Wounds; 2006 Sep; 5(3):144-8. PubMed ID: 16928670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RheoSorb: a specific adsorber for fibrinogen elimination in clinical situations with impaired rheology.
    Koll RA; Klinkmann J; Richter WO
    Artif Organs; 2002 Feb; 26(2):145-51. PubMed ID: 11879243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular changes in the diabetic foot.
    Schramm JC; Dinh T; Veves A
    Int J Low Extrem Wounds; 2006 Sep; 5(3):149-59. PubMed ID: 16928671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodialysis is associated with changes in cutaneous microcirculation in diabetes mellitus.
    Beckert S; Sundermann K; Wolf S; Königsrainer A; Coerper S
    Diabet Med; 2009 Jan; 26(1):89-92. PubMed ID: 19125767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of air-plasma flow for the correction of microcirculation disorders during the treatment of diabetic foot syndrome].
    Duvanskiĭ VA; Dzagnidze NS
    Georgian Med News; 2005 Dec; (129):12-6. PubMed ID: 16444019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiopathology of Vascular Complications of Diabetic Foot].
    Arana-Conejo V; Domingo Méndez J
    Gac Med Mex; 2003; 139(3):255-64. PubMed ID: 12872418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal fibrinogen adsorption--efficacy, selectivity and safety in healthy subjects and patients with foot ulcers.
    Richter WO; Schneidewind JM; Ramlow W; Jahn P; Jung N; Nielebock E; Tachezy H; Eulitz K; Koll R; Klinkmann J
    Transfus Apher Sci; 2002 Feb; 26(1):15-27. PubMed ID: 11931374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the diabetic foot.
    Akbari CM; Macsata R; Smith BM; Sidawy AN
    Semin Vasc Surg; 2003 Mar; 16(1):3-11. PubMed ID: 12644970
    [No Abstract]   [Full Text] [Related]  

  • 10. Current management of the diabetic foot.
    LoGerfo FW; Misare BD
    Adv Surg; 1996; 30():417-26. PubMed ID: 8960346
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of fibrinogen and alpha2-macroglobulin and their apheretic elimination on general blood rheology and rheological characteristics of red blood cell aggregates.
    Kirschkamp T; Schmid-Schönbein H; Weinberger A; Smeets R
    Ther Apher Dial; 2008 Oct; 12(5):360-7. PubMed ID: 18937718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].
    Svetukhin AM; Zemlianoĭ AB; Orudzheva SA; Titova MI; Rudneva VG; Elagina LV; Pavlova MV; Terekhova RP; Bozh'eva EI; Makhmudova LS
    Ter Arkh; 2001; 73(4):31-3. PubMed ID: 11494443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcirculation of the diabetic foot.
    Dinh T; Veves A
    Curr Pharm Des; 2005; 11(18):2301-9. PubMed ID: 16022669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic foot: new insights into pathophysiology and treatment].
    van Sloten TT; Friederichs SA; Huijberts MS; Schaper NC
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2400-5. PubMed ID: 19055139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Caribbean experience with the diabetic foot management of the diabetic foot.
    Walrond ER
    West Indian Med J; 2001 Mar 1-4; 50 Suppl 1():24-6. PubMed ID: 15973811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of diabetic microvascular disease in the development of foot wounds.
    Henderson EA
    J Wound Care; 2007 Jun; 16(6):275-8. PubMed ID: 17722525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic foot management in the elderly.
    Plummer ES; Albert SG
    Clin Geriatr Med; 2008 Aug; 24(3):551-67, viii. PubMed ID: 18672189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes.
    Khaodhiar L; Dinh T; Schomacker KT; Panasyuk SV; Freeman JE; Lew R; Vo T; Panasyuk AA; Lima C; Giurini JM; Lyons TE; Veves A
    Diabetes Care; 2007 Apr; 30(4):903-10. PubMed ID: 17303790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen adsorption in the diabetic foot syndrome and peripheral arterial occlusive disease: first clinical experience.
    Richter WO; Jahn P; Jung N; Nielebock E; Tachezy H
    Ther Apher; 2001 Oct; 5(5):335-9. PubMed ID: 11778917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorheological disturbances as a marker of diabetic foot syndrome deterioration.
    Khodabandehlou T; Le Dévéhat C
    Clin Hemorheol Microcirc; 2004; 30(3-4):219-23. PubMed ID: 15258346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.